]> 2026-07-31T16:29:08+00:00 WBR0629 0 en 4 This number is incorrect. 8 16 This number is incorrect. 32 This number is incorrect. 64 This number is incorrect. Biostatistics/Epidemiology A study addresses the secondary prevention of acute coronary syndrome (ACS) using a novel cholesterol-lowering agent. After 5 years, follow-up of 4400 ACS patients reveals recurrence of at least 1 ACS event among 200 out of 2000 subjects who were administered the novel agent vs. 540 out of 2400 subjects who were administered standard therapy. Through 5 years, how many patients should be administered the novel agent to prevent at least 1 ACS event? B Cardiology 2020-10-28T01:14:05Z 2459150.5514468 WBR0629